Skip to main content
Journal cover image

Associations of comorbid substance use disorders with clinical outcomes in schizophrenia using electronic health record data.

Publication ,  Journal Article
Patel, R; Chan, KMY; Palmer, EOC; Valko, M; Guruswamy, G; Ker, S; Batra, G; Rentería, ME; Kollins, SH
Published in: Schizophr Res
October 2023

BACKGROUND AND HYPOTHESIS: Schizophrenia and comorbid substance use disorders (SUDs) are associated with poor treatment outcomes but differences between the associations of different SUDs with clinical outcomes are poorly characterized. This study examines the associations of comorbid SUDs with clinical outcomes in schizophrenia using a largescale electronic health record (EHR) database. DESIGN: Real-world data (RWD) analysis using the NeuroBlu database; de-identified EHR data were analysed. Multivariable logistic regression, Poisson and CoxPH models were used to compare the associations of specific comorbid SUDs with outcome variables. RESULTS: Comorbid SUD was significantly different on all outcome measures compared to no SUD (U = 1.44e7-1.81e7, all ps < .001), except number of unique antipsychotics (U = 1.61e7, p = .43). Cannabis (OR = 1.58, p < .001) and polysubstance (OR = 1.22, p = .007) use disorders were associated with greater CGI-S. Cannabis (IRR = 1.13, p = .003) and polysubstance (IRR = 1.08, p = .003) use disorders were associated with greater number of unique antipsychotics prescribed, while cocaine (HR = 1.87, p < .001), stimulants (HR = 1.64, p = .024), and polysubstance (HR = 1.46, p < .001) use disorders were associated with a shorter time to antipsychotic discontinuation. Conversely, alcohol use (IRR = 0.83, p < .001), cocaine use (IRR = 0.61, p < .001), opioid use (IRR = 0.61, p < .001), stimulant use (IRR = 0.57, p < .001) and polysubstance use (IRR = 0.87, p < .001) disorders were associated fewer inpatient days. CONCLUSION: Comorbid SUDs were generally associated with greater CGI-S and poorer clinical outcomes in patients with schizophrenia. Treatment strategies should target not only schizophrenia symptoms but also comorbid SUD to improve management of both conditions.

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

Schizophr Res

DOI

EISSN

1573-2509

Publication Date

October 2023

Volume

260

Start / End Page

191 / 197

Location

Netherlands

Related Subject Headings

  • Substance-Related Disorders
  • Schizophrenia
  • Psychiatry
  • Humans
  • Electronic Health Records
  • Comorbidity
  • Cocaine-Related Disorders
  • Cocaine
  • Cannabis
  • Antipsychotic Agents
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Patel, R., Chan, K. M. Y., Palmer, E. O. C., Valko, M., Guruswamy, G., Ker, S., … Kollins, S. H. (2023). Associations of comorbid substance use disorders with clinical outcomes in schizophrenia using electronic health record data. Schizophr Res, 260, 191–197. https://doi.org/10.1016/j.schres.2023.08.023
Patel, Rashmi, Kelly M. Y. Chan, Emily O. C. Palmer, Matthew Valko, Guruprabha Guruswamy, Sheryl Ker, Gunjan Batra, Miguel E. Rentería, and Scott H. Kollins. “Associations of comorbid substance use disorders with clinical outcomes in schizophrenia using electronic health record data.Schizophr Res 260 (October 2023): 191–97. https://doi.org/10.1016/j.schres.2023.08.023.
Patel R, Chan KMY, Palmer EOC, Valko M, Guruswamy G, Ker S, et al. Associations of comorbid substance use disorders with clinical outcomes in schizophrenia using electronic health record data. Schizophr Res. 2023 Oct;260:191–7.
Patel, Rashmi, et al. “Associations of comorbid substance use disorders with clinical outcomes in schizophrenia using electronic health record data.Schizophr Res, vol. 260, Oct. 2023, pp. 191–97. Pubmed, doi:10.1016/j.schres.2023.08.023.
Patel R, Chan KMY, Palmer EOC, Valko M, Guruswamy G, Ker S, Batra G, Rentería ME, Kollins SH. Associations of comorbid substance use disorders with clinical outcomes in schizophrenia using electronic health record data. Schizophr Res. 2023 Oct;260:191–197.
Journal cover image

Published In

Schizophr Res

DOI

EISSN

1573-2509

Publication Date

October 2023

Volume

260

Start / End Page

191 / 197

Location

Netherlands

Related Subject Headings

  • Substance-Related Disorders
  • Schizophrenia
  • Psychiatry
  • Humans
  • Electronic Health Records
  • Comorbidity
  • Cocaine-Related Disorders
  • Cocaine
  • Cannabis
  • Antipsychotic Agents